Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

GoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee out-of-pocket costsBrief Summary:GoodRx to ...

Detroit-based advocacy group Mothering Justice Action Fund hosted its annual State of the Mama event on Thursday night “These are not abstract policy conversations. These are our realities,” said ...

The International Association of Top Professionals (IAOTP) will honor Jason Johnson at their annual awards gala in NYC ...

— Norwich University alumnus Brigadier General William McCollough ’91, VSM, the 56th Commandant of Cadets and the Vice ...

(the 'Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced ...

On February 5, 2026, President Trump released another namesake initiative, this time aimed at prescription drug prices. The new program, TrumpRx, is advertised as delivering “the world’s lowest prices ...

When Jayant Mishra was diagnosed with psoriatic arthritis last year, the California resident understood he’d likely need ...